CQ7. What Are the Blood Chemistry Data That Increase the Likelihood of Thyroid Malignancy and What Are Their Sensitivity, Specificity, and Likelihood Ratio?

  • Shinichi Suzuki
  • Nobuhiro Fukunari
  • Kaori Kameyama
  • Megumi Miyakawa
  • Katsuhiro Tanaka
  • Yatsuka Hibi


Of the possible diagnostic markers of thyroid cancer, CEA and calcitonin have been established as diagnostic markers for medullary carcinoma since the 1970s [1, 2]. TSH and thyroglobulin, which have been evaluated as possible markers, are also discussed.


Thyroid Cancer Thyroid Nodule Diagnostic Marker Thyroid Tumor Medullary Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Pacini F, Fontanelli M, Fugazzola L et al (1994) Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab 78:826–829 (PS)PubMedCrossRefGoogle Scholar
  2. 2.
    Iacobone M, Niccoli-Sire P, Sebag F et al (2002) Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels. World J Surg 26:886–890 (PS)PubMedCrossRefGoogle Scholar
  3. 3.
    Mirallie E, Iacobone M, Sebag F et al (2004) Results of surgical treatment of sporadic medullary thyroid carcinoma following routine measurement of serum calcitonin. Eur J Surg Oncol 30: 790–795 (PS)PubMedCrossRefGoogle Scholar
  4. 4.
    Copper DS, Doherty GM, Haugen BR et al (2006) Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:109–142 (SR<RS>)CrossRefGoogle Scholar
  5. 5.
    Machens A, Ukkat J, Hauptmann S et al (2007) Abnormal carcinoembryonic antigen levels and medullary thyroid cancer progression: a multivariate analysis. Arch Surg 142:289–293 (RS)PubMedCrossRefGoogle Scholar
  6. 6.
    Boelaert K, Horacek J, Holder RL et al (2006) Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab 91:4295–4301 (PS)PubMedCrossRefGoogle Scholar
  7. 7.
    Polyzos SA, Kita M, Efstathiadou Z et al (2008) Serum thyrotropin concentration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodules. J Cancer Res Clin Oncol 134:953–960 (RS)PubMedCrossRefGoogle Scholar
  8. 8.
    Besic N, Sesek M, Peric B et al (2008) Predictive factors of carcinoma in 327 patients with follicular neoplasm of the thyroid. Med Sci Monit 14:CR459–CR467 (RS)PubMedGoogle Scholar
  9. 9.
    Hocevar M, Auersperg M (1998) Role of serum thyroglobulin in the pre-operative evaluation of follicular thyroid tumours. Eur J Surg Oncol 24:553–557 (RS)PubMedCrossRefGoogle Scholar
  10. 10.
    Hashimoto T, Mizugami T, Michigishi T et al (1989) (Text in Japanese) Rinsho Byori 37:122–130 (RS)Google Scholar

Copyright information

© Springer Japan 2013

Authors and Affiliations

  • Shinichi Suzuki
    • 1
  • Nobuhiro Fukunari
    • 2
  • Kaori Kameyama
    • 3
  • Megumi Miyakawa
    • 4
  • Katsuhiro Tanaka
    • 5
  • Yatsuka Hibi
    • 6
  1. 1.Department of Organ Regulation SurgeryFukushima Medical University, School of MedicineFukushimaJapan
  2. 2.Department of SurgeryShowa University Northern Yokohama HospitalYokohamaJapan
  3. 3.Department of Diagnostic PathologyKeio University School of MedicineTokyoJapan
  4. 4.Endocrine CenterToranomon HospitalTokyoJapan
  5. 5.Department of Breast and Thyroid SurgeryKawasaki Medical SchoolKurashikiJapan
  6. 6.Department of Endocrine SurgeryFujita Health University School of MedicineToyoakeJapan

Personalised recommendations